Ronenn Roubenoff

Global Head, Translational Medicine Discovery & Profiling

Novartis Institutes for Biomedical Research (NIBR)

Ronenn trained in internal medicine, epidemiology, and rheumatology at Johns Hopkins, and did postdoctoral training in inflammation and nutrition at Tufts University. He is currently Global Head of Translational Medicine Discovery and Profiling at Novartis Institutes for Biomedical Research (NIBR), based in Basel, Switzerland. He is also Adjunct Professor of Medicine and Nutrition at Tufts. He is an internationally recognized authority on sarcopenia, translational medicine, and the use of biomarkers in drug development. He has published over 270 papers in the medical literature (h-index 100), as well as writing for lay audiences. He has won multiple awards, including membership in the Alpha Omega Alpha and Delta Omega honor societies; Fellow of the American College of Physicians and the American College of Rheumatology; and the Robert H. Herman Memorial Award of the American Society for Nutrition.

Home link
The leading producer of educational events and resources in the life sciences
Contact
40-41 Museum Street
London
WC1A 1LT, UK
T: +44 (0) 207 092 3494
Overview

Henry Stewart Conference Studies LLP is a limited liability partnership, registered in England, registration number OC334769 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events Ltd is a limited company, registered in England, registration number 06532399 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events, Inc. is a corporation incorporated in the State of Delaware, USA having a business office at PKF O’Connor Davies LLP, 665 Fifth Avenue, New York NY 10022.
© Henry Stewart Conference Studies LLP or its affiliates.